Product correctly added to cart.

O-[4-((2-Oxo-1,2-dihydroquinolin-7-yl)oxy)butyl] Brexpiprazole (>90%)
View 3D

TRC logo

O-[4-((2-Oxo-1,2-dihydroquinolin-7-yl)oxy)butyl] Brexpiprazole (>90%)

CAS: 2116542-21-1

Ref. TR-O855355

1mg
Discontinued
5mg
Discontinued
10mg
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
O-[4-((2-Oxo-1,2-dihydroquinolin-7-yl)oxy)butyl] Brexpiprazole (>90%)
Synonyms:
  • 7-(4-((7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2-yl)oxy)butoxy)quinolin-2(1H)-one
Description:

Applications O-[4-((2-Oxo-1,2-dihydroquinolin-7-yl)oxy)butyl] Brexpiprazole is a derivative of Brexpiprazole (B677385) which is a drug candidate useful in treatment and prevention of mental disorders including CNS disorders.
References Yamashita, H., et al.: PCT Int. Appl., WO 2006112464 A1 20061026 (2006)

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:

Chemical properties

Molecular weight:
648.81
Formula:
C38H40N4O4S
Purity:
>90%
Color/Form:
Light Brown to Orange Solid
InChI:
InChI=1S/C38H40N4O4S/c43-37-14-10-28-8-12-30(26-33(28)39-37)45-23-3-4-24-46-38-15-11-29-9-13-31(27-34(29)40-38)44-22-2-1-17-41-18-20-42(21-19-41)35-6-5-7-36-32(35)16-25-47-36/h5-16,25-27H,1-4,17-24H2,(H,39,43)
InChI key:
InChIKey=KVKIZAUWWJSARG-UHFFFAOYSA-N
SMILES:
O=c1ccc2ccc(OCCCCOc3ccc4ccc(OCCCCN5CCN(c6cccc7sccc67)CC5)cc4n3)cc2[nH]1
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: TR-O855355 O-[4-((2-Oxo-1,2-dihydroquinolin-7-yl)oxy)butyl] Brexpiprazole (>90%)

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".